| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $319.9M | -14.2% |
| Cost of Revenue | $200.6M | -17.7% |
| Gross Profit | $119.3M | -7.5% |
| R&D Expense | $16.9M | -2.4% |
| SG&A Expense | $30.4M | +7.0% |
| Operating Income | $27.5M | +37.4% |
| Interest Expense | $7.9M | -4.8% |
| Pre-tax Income | $16.8M | +57.4% |
| Income Tax | $1.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.0M | +30.5% |
| Accounts Receivable | $76.8M | -17.5% |
| Inventory | $69.2M | -2.8% |
| Current Assets | $173.8M | -7.7% |
| Total Assets | $269.1M | -10.0% |
| Current Liabilities | $87.7M | -29.1% |
| Long-term Debt | $55.7M | +13.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $35.5M | +515.5% |
| Capital Expenditures | $1.4M | -71.1% |
| Investing Cash Flow | $1.1M | +101.3% |
| Financing Cash Flow | -$32.6M | -145.9% |
| Free Cash Flow | $34.0M | +3918.8% |
| +119.4% |
| Net Income | $15.7M | -2.8% |
| EPS (Basic) | $0.78 | -3.7% |
| EPS (Diluted) | $0.77 | -1.3% |
| Total Liabilities |
| $140.6M |
| -21.1% |
| Stockholders' Equity | $128.5M | +6.5% |